SINOPHARM (01099): The mid-term operating profit of Sinopharm Medical Equipment is 599 million yuan, a year-on-year decrease of 12.34%.
China National Pharmaceutical Group (01099) announced the six-month performance of China National Pharmaceutical Equipment for the period ending June 30, 2026. The company achieved operating revenue of 36.492 billion yuan (RMB, the same below), a year-on-year increase of 0.36%; operating profit of 599 million yuan, a year-on-year decrease of 12.34%; and comprehensive income attributable to the owners of the parent company of 287 million yuan, a year-on-year decrease of 2.56%.
SINOPHARM (01099) announced its performance for the six months ending on June 30, 2026. The company achieved operating revenue of 36.492 billion yuan (RMB, the same below), an increase of 0.36% year-on-year; operating profit of 599 million yuan, a decrease of 12.34% year-on-year; and comprehensive income attributable to owners of the parent company of 287 million yuan, a decrease of 2.56% year-on-year.
Related Articles
YTO INTL EXP (06123): Wang Lixiu resigned as a non-executive director.
NANSHAN AL INTL (02610) announced its interim results, with shareholders' profit attributable to them at $62.7 million, a decrease of 74.8% compared to the previous year.
TYSAN HOLDINGS (00687) will distribute an interim dividend of HKD 0.03 per share on September 25th.
YTO INTL EXP (06123): Wang Lixiu resigned as a non-executive director.
NANSHAN AL INTL (02610) announced its interim results, with shareholders' profit attributable to them at $62.7 million, a decrease of 74.8% compared to the previous year.
TYSAN HOLDINGS (00687) will distribute an interim dividend of HKD 0.03 per share on September 25th.
RECOMMEND
